Relmada Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $817k | 118k | 6.92 |
| 2024-06-30 | $3.4k | 1.1k | 3.00 |
| 2024-03-31 | $5.5k | 1.2k | 4.65 |
| 2023-12-31 | $4.9k | 1.2k | 4.14 |
| 2023-09-30 | $3.5k | 1.2k | 3.00 |
| 2023-06-30 | $8.5k | 3.4k | 2.46 |
| 2023-03-31 | $85k | 38k | 2.26 |
| 2022-12-31 | $128k | 37k | 3.50 |
| 2022-09-30 | $1.3M | 36k | 37.01 |
| 2022-06-30 | $635k | 33k | 18.99 |
| 2022-03-31 | $582k | 22k | 27.00 |
| 2021-12-31 | $351k | 16k | 22.52 |
| 2021-09-30 | $415k | 16k | 26.22 |
| 2021-06-30 | $485k | 15k | 32.01 |
| 2021-03-31 | $577k | 16k | 35.20 |
| 2020-12-31 | $549k | 17k | 32.05 |
| 2020-09-30 | $602k | 16k | 37.63 |
| 2020-06-30 | $798k | 18k | 44.72 |